Healios K.K. (OTCMKTS:HLOSF – Get Free Report) shares shot up 58.5% during mid-day trading on Friday . The stock traded as high as $3.17 and last traded at $3.17. 100 shares were traded during trading, a decline of 95% from the average session volume of 1,983 shares. The stock had previously closed at $2.00.
Healios K.K. Trading Up 58.5%
The firm has a 50-day moving average of $2.13 and a 200-day moving average of $1.61.
Healios K.K. Company Profile
Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease.
See Also
- Five stocks we like better than Healios K.K.
- What is the Nasdaq? Complete Overview with History
- Apple’s Quiet HomePad Delay Could Be Its Loudest Move Yet
- Investing in Commodities: What Are They? How to Invest in Them
- e.l.f. Gets Back on the Shelf! It’s Not Too Late to Buy In!
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Near 52-Week Lows, These 3 Mid-Cap Stocks Are Worth a Look
Receive News & Ratings for Healios K.K. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healios K.K. and related companies with MarketBeat.com's FREE daily email newsletter.
